Rare Cancers Bill 2024-2025
The Rare Cancers Bill 2024-2025 had its second reading on Friday 14 March 2025. It was considered in Public Bill Committee on 2 July 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.

A debate has been scheduled in Westminster Hall for 9.30am on Wednesday 9 November 2022 on Huntington's disease. The debate will be opened by Hilary Benn MP.
Commons Library debate pack - Huntington's disease (271 KB , PDF)
Huntington’s disease is a condition that stops parts of the brain working properly over time.[1]
The underlying reason for Huntington’s disease is damage to and the death of some brain cells (neurons), caused by faulty genes. An affected person will inherit these genes from one, or both, of their parents.
In some cases, a person without a family history can develop the disease, but it has been suggested that in such cases, a parent did in fact have Huntington’s disease but did not receive a diagnosis. [2]
Huntington’s disease is a degenerative condition, meaning that it gets progressively worse over time, and is usually fatal after a period of up to 20 years.
The symptoms of Huntington’s disease can include:
Huntingdon’s disease is a rare condition; the Huntington’s Disease Association estimates that 8,000 people in the UK have the condition.[4]
An NHS webpage provides further information about Huntington’s disease.
This pack contains information on treatment, clinical research and NHS services for Huntington’s disease, as well as recent PQs, news and press releases.
[1] NHS, Huntington’s disease, accessed 7 November 2022
[2] NHS, Huntington’s disease, accessed 7 November 2022
[3] NHS, Huntington’s disease, accessed 7 November 2022
[4] Huntington’s Disease Association, Impact report, 2019
Commons Library debate pack - Huntington's disease (271 KB , PDF)
The Rare Cancers Bill 2024-2025 had its second reading on Friday 14 March 2025. It was considered in Public Bill Committee on 2 July 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.
This briefing focuses on two disease-modifying dementia drugs that are currently being appraised by the National Institute for Health and Care Excellence (NICE): lecanemab and donanemab
On 8 July 2025, there will be a Commons debate on alcohol and cancer. The debate will be led by Cat Smith MP. The Library will publish a briefing ahead of the debate.